Search research articles
Contact Us
Filters
Showing results (191-200 of 425) with videos related to
Page
of 43
Sort By:
Journal of Medical Economics
|
January 19, 2017
Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context
Peter P Toth, Mark Danese, Guillermo Villa, et al.
Lipids in Health and Disease
|
October 6, 2017
Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans
Mohsen Mazidi, Andre Pascal Kengne, Dimitri P Mikhailidis, et al.
Current Atherosclerosis Reports
|
November 10, 2025
Beyond LDL Cholesterol Reduction: Pleiotropic Profiling of Statins
Tanesh Ayyalu, Tia Bimal, Maya S Safarova, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
August 21, 2019
Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients
Hamiyet Donmez-Altuntas, Fahri Bayram, Ayse N Coskun-Demirkalp, et al.
European Heart Journal
|
September 1, 2018
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine
Ulrich Laufs, Ricardo Dent, Paul J Kostenuik, et al.
Preventive Cardiology
|
November 7, 2006
Gender differences in adhering to national guidelines in a community lipid clinic
Nicolas W Shammas, Jon H Lemke, Judi Deckert, et al.
Current Atherosclerosis Reports
|
February 17, 2026
Correction: Beyond LDL Cholesterol Reduction: Pleiotropic Profiling of Statins
Tanesh Ayyalu, Tia Bimal, Maya S Safarova, et al.
Archives of Medical Science : AMS
|
May 21, 2025
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings
Bożena Sosnowska, Peter P Toth, Alexander C Razavi, et al.
Preventive Cardiology
|
April 11, 2008
Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery
Nicolas W Shammas, Eric J Dippel, Michael Jerin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 11, 2018
Management of Statin Intolerance in 2018: Still More Questions Than Answers
Peter P Toth, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Page
of 43
Search research articles
Search
Showing results (191-200 of 425) with videos related to
Sort By:
Page
of 43
Journal of Medical Economics
|
January 19, 2017
Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context
Peter P Toth, Mark Danese, Guillermo Villa, et al.
Lipids in Health and Disease
|
October 6, 2017
Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans
Mohsen Mazidi, Andre Pascal Kengne, Dimitri P Mikhailidis, et al.
Current Atherosclerosis Reports
|
November 10, 2025
Beyond LDL Cholesterol Reduction: Pleiotropic Profiling of Statins
Tanesh Ayyalu, Tia Bimal, Maya S Safarova, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
August 21, 2019
Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients
Hamiyet Donmez-Altuntas, Fahri Bayram, Ayse N Coskun-Demirkalp, et al.
European Heart Journal
|
September 1, 2018
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine
Ulrich Laufs, Ricardo Dent, Paul J Kostenuik, et al.
Preventive Cardiology
|
November 7, 2006
Gender differences in adhering to national guidelines in a community lipid clinic
Nicolas W Shammas, Jon H Lemke, Judi Deckert, et al.
Current Atherosclerosis Reports
|
February 17, 2026
Correction: Beyond LDL Cholesterol Reduction: Pleiotropic Profiling of Statins
Tanesh Ayyalu, Tia Bimal, Maya S Safarova, et al.
Archives of Medical Science : AMS
|
May 21, 2025
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings
Bożena Sosnowska, Peter P Toth, Alexander C Razavi, et al.
Preventive Cardiology
|
April 11, 2008
Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery
Nicolas W Shammas, Eric J Dippel, Michael Jerin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 11, 2018
Management of Statin Intolerance in 2018: Still More Questions Than Answers
Peter P Toth, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Page
of 43